Deciding which head-injured patients should be transferred to a neurosurgical unit can be difficult. Traditional criteria emphasise the development of deteriorating responsiveness but lead to delayed diagnosis and to avoidable mortality and morbidity. To discover if a more liberal admission policy improved results a study was conducted analysing data collected prospectively from 683 patients who had a traumatic intracranial haematoma evacuated in the Glasgow neurosurgical unit between 1974 and 1980. In the first four years, before the change in policy, mortality was 38% but decreased to 29% afterwards. This reflected a reduction in the proportion of patients who talked after injury but who deteriorated into coma before operation-that is, 31 % before the change in policy, 16% afterwards.
Introduction
Reports from centres in which most head-injured patients are admitted directly to neurosurgical care show clearly that the earlier a patient with a traumatic haematoma undergoes evacuation of clot the better is the patient's outcome.' 2 Yet head-injured patients throughout most of Britain are admitted initially to a primary surgical ward, and only 5"', are subsequently transferred to a neurosurgical unit.3 Unfortunately, according to several studies the criteria widely used to select patients for transfer lead to avoidable mortality and morbidity in those with a traumatic intracranial haematoma.4-I The reason for this is that it has been customary to suspect that a patient has a significant traumatic intracranial haematoma only after responsiveness deteriorates or if he fails to improve after several days; this leads to delayed diagnosis, so that by the time the clot is evacuated many such patients have already sustained irreversible secondary brain damage.4
There are several reasons for restricting severely the number of head-injured patients admitted to neurosurgical units. One is the availability of neurosurgical beds in relation to the total number of head-injured patients. In the past another reason was that the appropriate investigation-that is, angiography-was difficult, invasive, and potentially dangerous and therefore justified only in those patients most obviously suffering from an intracranial complication. The increase in the number of patients with a clot that needed to be evacuated was unexpected, and this alone might have influenced the results.
In practice, the additional patients in the second period included both severely and mildly injured people so that overall the two series were closely similar with respect to important prognostic factors such as age, the type of haematoma, and the proportion of patients with severe primary brain damage. The presence of brain damage that is severe from the start is reflected in the patient being in coma from the time of injury, and it is these patients who now account for the major proportion of mortality and morbidity in patients transferred to the neurosurgical unit. In the first period many such patients probably remained in the primary surgical ward and either died or survived with disability. Indeed, in Merseyside, where only 1 201) of patients admitted for head injuries are transferred to the regional suirgical unit, deaths from an intracranial haematoma occur as often in general hospitals as in the regional unit. 7 Studies are in progress to establish if the change in admission policy in Glasgow has reduced deaths in the general hospitals in our region.
Although more mildly injured patients were admitted during the second period, the improved outcome cannot be explained by unnecessary operations on patients with a small haematoma who would have recovered without surgery. CT scanning was available in both periods and neurosurgeons in Glasgow have made a point of adopting an expectant policy in the management of these kinds of haematomas.'5 During the second period of the study more than 100 such haematomas were managed without operation. The most likely reason for the improved results in the second series was that a smaller proportion of patients had deteriorated into coma before operation; this indicates that fewer patients had developed irreversible secondary brain damage.
Several different methods are advocated that aim to minimise delay in.the detection of a traumatic intracranial haematoma. In North America and in a few British centres the view is that as many head-injured patients as possible, including all those with a mild injury, should be managed by neurosurgeons. Another view is that scanners should be available in general hospitals so that haematomas could be detected there'; the patient might then be operated on in the general hospital or sent to a regional neurosurgical centre. Both approaches are expensive in resources; moreover, without an alteration in the clinical criteria for investigation neither method would guarantee reduced delay and improved results. Investigation outside a neurosurgical unit might even increase delay. The best method would be to establish simple clinical criteria for identifying before deterioration which head-injured patients have a high risk of haematoma so that these could be transferred for scanning and possible operation.
Even after the change in policy only 7"' of head-injured patients admitted to hospital in the west of Scotland were transferred to the neurosurgical unit. The increase in admissions to the neurosurgical unit was feasible because patients were returned rapidly to the referring unit after a significant intracranial lesion had been excluded and also because a few additional beds became available. Avoidable mortality and morbidity are still occurring and their elimination may require the investigation of even more patients-possibly at least 10, of those presently admitted to hospital. Additional neurosurgical facilities for the investigation of head injuries might be provided from the resources that would be released by a reduction in the total number of admissions for head injury. This 
We have reported' the use preoperatively of the convertingenzyme inhibitor captopril in the treatment of hypertension associated with unilateral renal artery stenosis. Long-term captopril promised well as a predictor of the blood-pressure response to operation, although this requires further study. We have also reported that oral captopril in a dose of 150 mg three times daily produces sustained suppression of the plasma angiotensin II concentration throughout 24 hours.2 Captopril, however, has been associated with several toxic effects which may be attributable to the sulphydryl group in its molecule.3 Although the use of lower doses of captopril may avoid at least some of these unwanted effects, it appears important to consider alternative converting-enzyme inhibitors. Enalapril maleate (MK421),4 an orally active converting-enzyme inhibitor devoid of a sulphydryl group, may permit long-term inhibition of angiotensin II formation without incurring the side effects seen with captopril. We report preliminary results of the use of longterm enalapril in five patients with hypertension and renal artery stenosis. Particular attention was paid to the magnitude and duration of the reduction in plasma angiotensin II concentrations.
Patients and methods
Five patients (two women) aged 38-56 years gave informed consent to the study, which was approved by the hospital's ethical supervisory committee. All patients had unilateral renal artery stenosis shown by intravenous pyelography, renal arteriography, isotope nephrography,'5 bilateral renal vein renin measurements, and ureteric catheter studies.' 6 Four had radiological evidence of atheroma and one fibromuscular hyperplasia. All had normal serum electrolyte values and renal
